Phase 2 trial of defactinib in combination with avutometinib in patients with advanced diffuse-type gastric cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...

DelveInsight’s, “Squamous Cell Carcinoma Pipeline Insight” report provides comprehensive insights about 75+ companies and 80+ ...

Transarterial infusion chemotherapy and embolization (TAICE) as a pre-operative therapy for patients with locally advanced gastric cancer (LAGC): A prospective, single-arm, pilot study.

Results from the Phase III NRG Oncology RTOG 0920 (NRG-RTOG 0920) trial assessing postoperative radiotherapy with or without ...

High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...

Shares of Exelixis EXEL were down 5.13% on Jan. 24, following a downgrade in rating by analysts at Oppenheimer. Oppenheimer ...

Jan. 30, 2025 — A new study has highlighted the potential of resveratrol, a natural compound found in grapes, blueberries, and raspberries, to enhance female fertility. The systematic review ...

The whole experience also changed how Doucette saw her arm and, by extension, cancer and herself. For years, Doucette says, she viewed her right arm as nothing more than a burden, the source of ...

The combination of brain radiotherapy and chemoimmunotherapy “resulted in promising intracranial and systemic anti-tumor activity, with a manageable safety profile,” researchers wrote.

Merck & Co is pressing home its precious advantage in first line non-small cell ... the non-squamous NSCLC market, which represents about 75% of the overall multi-billion dollar lung cancer ...

If approved, the new drug may be tolerated ... Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious ...